Shiva GopalVasishta, MD has been a practicing Neurologist for over 40 years. He currently practices in Voorhees, New Jersey at Eastern Neurodiagnostic Associates. The complicated, yet promising field of neurological study has always fascinated Vasishta. He’s dedicated his entire adult life to advancing the medical treatment and care of patients suffering from various forms of neurology trauma and conditions.Dr. Shiva GopalVasishta attended Government Medical College and graduated in 1979. His residency was completed at Boston City Hospital. Among his neurological focus, Dr. Shiva GopalVasishta also specializes in Psychiatry. His New Jersey practice also supports the Spanish language.
Something very dear to Vasishta’s career is the clinical trial results of a revolutionary therapy treatment for patients with multiple sclerosis (MS). The new evidence suggests that high-dose immunosuppressive therapy along with an immediate transplant of the patient’s own blood-forming stem cells could induce sustained remission of relapsing-remitting MS. MS is an autoimmune disease that causes the body’s immune system to attack its central nervous system.
The trial was operated over a five-year period. The end results showed that 69 percent of trial participants that received the high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT) survived without experiencing progressive disability, relapse of MS symptoms, or any brain lesions. Another interesting fact is that none of the participants took any kind of MS medications after the HDIT/HCT treatment. Based on other studies performed by numerous other institutions, MS drugs have a lower success rate the HDIT/HCT.It’s important to remember that these results are only suggestive. There’s no definitive evidence that would suggest that this is a cure in any way. HDIT/HCT is the first step finding a cure.